|
|
| | 1,3-Di-HABA KanaMycin A Basic information |
| Product Name: | 1,3-Di-HABA KanaMycin A | | Synonyms: | O-3-AMino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[6-aMino-6-deoxy-α-D-glucopyranosyl-(1→4)]-N1,N3-bis[(2S)-4-aMino-2-hydroxy-1-oxobutyl]-2-deoxy-D-streptaMine;D-Streptamine, O-3-amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[6-amino-6-deoxy-α-D-glucopyranosyl-(1→4)]-N1,N3-bis[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-;Amikacin EP Impurity B;Amikacin Impurit Ⅱ(Impurit B)4-O-(3-Amino-3-deoxy-α-D-glucopyranosyl)-6-O-(6-amino-6-deoxy-α-D-glucopyranosyl)-1,3- N-2[(2S)-4-amino-2-hydroxy-butyryloxy]-2-deoxy-L-streptamine;Amikacin Sulfate ImpurityⅡ:(Amikacin EP Impurity B)4-O-(3-amino-3-deoxy-a-D-glucopyranosyl)-6-O-(6-amino-6-deoxy-a-D-glucopyranosyl)-1,3-N-2[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-L-streptamine;Amikacin Impurity 2（Amikacin EP Impurity B）;(2S,2'S)-N,N'-((1S,3R,4S,5R,6R)-4-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-5-hydroxycyclohexane-1,3-diyl)bis(4-amino-2-hydroxybutanamide);Amikacin Impurity 2 | | CAS: | 927821-99-6 | | MF: | C26H50N6O15 | | MW: | 686.71 | | EINECS: | | | Product Categories: | Amines;Intermediates & Fine Chemicals;Oligosaccharides;Pharmaceuticals | | Mol File: | 927821-99-6.mol |  |
| | 1,3-Di-HABA KanaMycin A Chemical Properties |
| Boiling point | 1136.6±65.0 °C(Predicted) | | density | 1.59±0.1 g/cm3(Predicted) | | solubility | Aqueous Acid (Slightly, Sonicated), Water (Slightly), Methanol (Slightly, Heated) | | pka | 12.94±0.70(Predicted) | | form | Solid | | color | White | | Stability: | Hygroscopic |
| | 1,3-Di-HABA KanaMycin A Usage And Synthesis |
| Uses | Amikacin (A578500) impurity B (EP). |
| | 1,3-Di-HABA KanaMycin A Preparation Products And Raw materials |
|